基于代谢组学技术逍遥散抗抑郁有效部位验证及机理研究
|
摘要
选题依据：抑郁症是一大类心理障碍,一般统称为“情绪障碍”。随着人们的生活压力越来越大,抑郁症的发病几率也越来越高。世界卫生组织已将其与癌症、艾滋病共同列为二十一世纪三大黑死病。出自于宋代《太平惠民和剂局方》的逍遥散在治疗抑郁症方面已经得到了现代临床效果的验证。但是,对于逍遥散抗抑郁的有效部位仍不明确。代谢组学作为一门新兴科学,在医学领域已经得到了广泛的应用,它采用核磁共振(NMR)、气相色谱-质谱联用(GC-MS)等现代仪器分析手段,分析生物样本如血液及尿液组织中内源性代谢物的变化,系统地分析机体生理病理状态的变化,而这种系统性与中医学的整体观相吻合。
目的：验证逍遥散抗抑郁有效部位及研究有效部位抗抑郁的作用机理。
方法：通过一系列的分离流程,得到逍遥散的石油醚部位(XY-A)、过大孔吸附树脂得30%、60%、95%乙醇洗脱部位(XY-B、 XY-C和XY-D)、药渣水提部位(XY-E)。通过复制慢性不可抑制轻度应激(CUMS)模型,选用雄性成年SD大鼠分别设模型组(MS)、空白组(NS)、石油醚组(XY-A)、30%乙醇洗脱组(XY-B)、60%乙醇洗脱组(XY-C)、95%乙醇洗脱组(XY-D)、药渣水提组(XY-E)、逍遥散复方组(XYS)8个组,给药组每日造模前给药。造模第21天采用代谢笼法收集尿液,并于造模结束后第22天收集血液,采用NMR、 GC-MS分析技术对所得生物样本进行测定,并采用SIMCA-P软件进行多元统计分析,对逍遥散抗抑郁有效部位及其抗抑郁作用机理进行分析。
结果：(1)代谢组学分析结果：
两种分析技术所得数据经多元统计分析均显示正常对照组和模型组能明显分开,表明造模成功,CUMS刺激引起了模型组代谢轮廓的变化。同时结合相应的载荷图和独立样本t检验,找到了引起差异的潜在生物标志物。正常对照组、模型组和逍遥散各部位组多元统计分析结果显示了逍遥散不同部位组对CUMS引起代谢物变化的不同的干预作用,其中逍遥散石油醚部位组(XY-A)与其他各部位组相比,离正常对照组最近,离模型组最远,表明其有明显的抗抑郁效果,效果最佳,且优于逍遥散复方组。逍遥散不同部位组可不同程度地调节潜在生物标志物趋向于正常对照组,而XY-A部位组可调节大部分的潜在生物标志物的水平趋向于正常对照组。
(2)逍遥散有效部位抗抑郁作用机理研究：
逍遥散石油醚部位组减弱或取消了外界刺激因素对机体的作用,使CUMS大鼠的代谢轮廓向正常对照组回归,其作用机理可能与琥珀酸、乳酸和甘氨酸等潜在生物标志物有关,从而调节了能量代谢、神经系统等生化代谢途径。
结论：本文成功地复制了慢性不可预知应激模型并通过对采集的生物样本(尿液、血液)的代谢组学分析,确定了逍遥散抗抑郁的有效部位和有效部位的抗抑郁作用机理。从逍遥散分离得到的五个不同极性部位,石油醚部位(XY-A)的抗抑郁效果最好,且优于逍遥散复方,这将为逍遥散的药效物质基础研究提供新的思路,为抗抑郁新药的开发和研究提供一定的基础。
RATIONALES:Depression is a serious mental illness, which is called as the "emotional disorder". With the increasing pressure of people's lives, the incidence of depression is the chance of getting higher and higher. It has been thank as the three black plague of the twenty-first century along cancer and AIDS by World Health Organization. Xiaoyaosan is from "Taiping huimin heji jufang" of Song Dynasty in the treatment of depression has been the validation of the clinical effects. However, the antidepressant effective fractions of the Xiaoyaosan is not clear. As an emerging science, metabonomics has been widely used in the medical field. The analytical methods like nuclear magnetic resonance (NMR), gas chromatography-mass spectrometry (GC-MS) and so on were used to analysis the change of endogenous metabolites from biological samples such as blood and urine and to analysis the body's physiological and pathological changes. The systemic feature is consistent with the principle of TCM.
OBJECTIVE:To explore the active fraction of Xiaoyaosan in producing antidepressant effect and to achieve the antidepressant mechanisms of the active fraction of Xiaoyaosan.
METHODS:Xiaoyaosan through a series of separation processes, petroleum ether fraction (XY-A),30%ethanol fraction (XY-B),60%ethanol fraction (XY-C),95%ethanol fraction (XY-D) and water fraction (XY-E) were obtained. Through copying the chronic unpredictable stress model, the healthy adult male Sprague-Dawley (SD) rats were divided into seven groups:control group, chronic unpredictable stress model group, petroleum ether fraction group,30%ethanol fraction group,60%ethanol fraction group,95%ethanol fraction group and water fraction group. Urine samples were collected in21days. Plasma samples were collected on22day. The NMR and GC-MS analysis techniques were applied to determine the biological samples. The SIMCA-P software for the multivariate analysis was used to analysis the active fraction of Xiaoyaosan in producing antidepressant effect and the antidepressant mechanisms of the active fraction of Xiaoyaosan.
RESULTS:(1) The results of metabolic studying:The data obtained from the two analysis techniques through multivariate statistical analysis showed the control group and model group can be clearly separated, which showed the model was successful. With the corresponding loading plot and independent sample T test, the potential biomarkers were found. The multivariate statistical analysis results for control group, model group and different fractions of Xiaoyaosan show that the different intervention effect of different fractions of Xiaoyaosan to the change of metabolites. Compared with the other fractions of Xiaoyaosan, the petroleum ether fraction of Xiaoyaosan was much closer to the control group and was the farthest away from the model group, indicating its significant antidepressant effect. The different fractions of Xiaoyaosan can regulate potential biomarkers tend to the normal control group, while the petroleum ether fraction of Xiaoyaosan can regulate most potential biomarker levels tend to control group.
(2) Antidepressant mechanism research of active fraction of Xiaoyaosan:the petroleum ether fraction of Xiaoyaosan abate or cancel the stimulus factors on the function of organism, so that the metabolic spectrum of CUMS rats tend to the control group. Its mechanism of action may be related to potential biomarkers likes succinic acid, lactic acid and glycine. They can regulate the aspect of energy metabolism, nerve system and so on.
CONCLUSION:The article copied the chronic unpredictable stress model successfully and analysis the collection of biological samples (urine, plasma) through metabolomics. The results identified the active fraction of Xiaoyaosan in producing antidepression and antidepressant mechanism of active fraction of Xiaoyaosan. The antidepressant effect of petroleum ether fraction is best in five different polar fractions of Xiaoyaosan, This will provide the new ideas for the study of material basis for the efficacy of Xiaoyaosan and provide the basis for the new drug research.
目的：验证逍遥散抗抑郁有效部位及研究有效部位抗抑郁的作用机理。
方法：通过一系列的分离流程,得到逍遥散的石油醚部位(XY-A)、过大孔吸附树脂得30%、60%、95%乙醇洗脱部位(XY-B、 XY-C和XY-D)、药渣水提部位(XY-E)。通过复制慢性不可抑制轻度应激(CUMS)模型,选用雄性成年SD大鼠分别设模型组(MS)、空白组(NS)、石油醚组(XY-A)、30%乙醇洗脱组(XY-B)、60%乙醇洗脱组(XY-C)、95%乙醇洗脱组(XY-D)、药渣水提组(XY-E)、逍遥散复方组(XYS)8个组,给药组每日造模前给药。造模第21天采用代谢笼法收集尿液,并于造模结束后第22天收集血液,采用NMR、 GC-MS分析技术对所得生物样本进行测定,并采用SIMCA-P软件进行多元统计分析,对逍遥散抗抑郁有效部位及其抗抑郁作用机理进行分析。
结果：(1)代谢组学分析结果：
两种分析技术所得数据经多元统计分析均显示正常对照组和模型组能明显分开,表明造模成功,CUMS刺激引起了模型组代谢轮廓的变化。同时结合相应的载荷图和独立样本t检验,找到了引起差异的潜在生物标志物。正常对照组、模型组和逍遥散各部位组多元统计分析结果显示了逍遥散不同部位组对CUMS引起代谢物变化的不同的干预作用,其中逍遥散石油醚部位组(XY-A)与其他各部位组相比,离正常对照组最近,离模型组最远,表明其有明显的抗抑郁效果,效果最佳,且优于逍遥散复方组。逍遥散不同部位组可不同程度地调节潜在生物标志物趋向于正常对照组,而XY-A部位组可调节大部分的潜在生物标志物的水平趋向于正常对照组。
(2)逍遥散有效部位抗抑郁作用机理研究：
逍遥散石油醚部位组减弱或取消了外界刺激因素对机体的作用,使CUMS大鼠的代谢轮廓向正常对照组回归,其作用机理可能与琥珀酸、乳酸和甘氨酸等潜在生物标志物有关,从而调节了能量代谢、神经系统等生化代谢途径。
结论：本文成功地复制了慢性不可预知应激模型并通过对采集的生物样本(尿液、血液)的代谢组学分析,确定了逍遥散抗抑郁的有效部位和有效部位的抗抑郁作用机理。从逍遥散分离得到的五个不同极性部位,石油醚部位(XY-A)的抗抑郁效果最好,且优于逍遥散复方,这将为逍遥散的药效物质基础研究提供新的思路,为抗抑郁新药的开发和研究提供一定的基础。
RATIONALES:Depression is a serious mental illness, which is called as the "emotional disorder". With the increasing pressure of people's lives, the incidence of depression is the chance of getting higher and higher. It has been thank as the three black plague of the twenty-first century along cancer and AIDS by World Health Organization. Xiaoyaosan is from "Taiping huimin heji jufang" of Song Dynasty in the treatment of depression has been the validation of the clinical effects. However, the antidepressant effective fractions of the Xiaoyaosan is not clear. As an emerging science, metabonomics has been widely used in the medical field. The analytical methods like nuclear magnetic resonance (NMR), gas chromatography-mass spectrometry (GC-MS) and so on were used to analysis the change of endogenous metabolites from biological samples such as blood and urine and to analysis the body's physiological and pathological changes. The systemic feature is consistent with the principle of TCM.
OBJECTIVE:To explore the active fraction of Xiaoyaosan in producing antidepressant effect and to achieve the antidepressant mechanisms of the active fraction of Xiaoyaosan.
METHODS:Xiaoyaosan through a series of separation processes, petroleum ether fraction (XY-A),30%ethanol fraction (XY-B),60%ethanol fraction (XY-C),95%ethanol fraction (XY-D) and water fraction (XY-E) were obtained. Through copying the chronic unpredictable stress model, the healthy adult male Sprague-Dawley (SD) rats were divided into seven groups:control group, chronic unpredictable stress model group, petroleum ether fraction group,30%ethanol fraction group,60%ethanol fraction group,95%ethanol fraction group and water fraction group. Urine samples were collected in21days. Plasma samples were collected on22day. The NMR and GC-MS analysis techniques were applied to determine the biological samples. The SIMCA-P software for the multivariate analysis was used to analysis the active fraction of Xiaoyaosan in producing antidepressant effect and the antidepressant mechanisms of the active fraction of Xiaoyaosan.
RESULTS:(1) The results of metabolic studying:The data obtained from the two analysis techniques through multivariate statistical analysis showed the control group and model group can be clearly separated, which showed the model was successful. With the corresponding loading plot and independent sample T test, the potential biomarkers were found. The multivariate statistical analysis results for control group, model group and different fractions of Xiaoyaosan show that the different intervention effect of different fractions of Xiaoyaosan to the change of metabolites. Compared with the other fractions of Xiaoyaosan, the petroleum ether fraction of Xiaoyaosan was much closer to the control group and was the farthest away from the model group, indicating its significant antidepressant effect. The different fractions of Xiaoyaosan can regulate potential biomarkers tend to the normal control group, while the petroleum ether fraction of Xiaoyaosan can regulate most potential biomarker levels tend to control group.
(2) Antidepressant mechanism research of active fraction of Xiaoyaosan:the petroleum ether fraction of Xiaoyaosan abate or cancel the stimulus factors on the function of organism, so that the metabolic spectrum of CUMS rats tend to the control group. Its mechanism of action may be related to potential biomarkers likes succinic acid, lactic acid and glycine. They can regulate the aspect of energy metabolism, nerve system and so on.
CONCLUSION:The article copied the chronic unpredictable stress model successfully and analysis the collection of biological samples (urine, plasma) through metabolomics. The results identified the active fraction of Xiaoyaosan in producing antidepression and antidepressant mechanism of active fraction of Xiaoyaosan. The antidepressant effect of petroleum ether fraction is best in five different polar fractions of Xiaoyaosan, This will provide the new ideas for the study of material basis for the efficacy of Xiaoyaosan and provide the basis for the new drug research.
引文
[1]施毅.浅谈中医对抑郁症的认识和治疗.新中医,2010,42,143-144.
[2]王祖承.精神病学.北京,人民卫生出版社,2002,2,112-125.
[3]郭小青,田正良,米金辉.抑郁症中医病因病机分析.浙江中医杂志,2002,37：374-375.
[4]王玲玲,刘兰英.针灸治疗抑郁症临床思路.针灸临床杂志,2003,19：7-9.
[5]杜元灏,李桂平.调神疏肝针法治疗郁证的理论基础.中国针灸,2005,25：143-146.
[6]李新纯,唐武,李庆.疏肝宁神汤治疗抑郁症60例.新中医,2003,35：60-61.
[7]张金茹.小柴胡汤治疗抑郁症40例.北京中医,2003,22：38-39.
[8]贾爱民,温霞.涤痰汤加减治疗抑郁症13例.河南中医,2003,23：26.
[9]张秋菊,王成永,程惠娟等.白金散对绝望行为动物模型的抗抑郁作用及其机理研究.中国中医药科技,2004,11：146-147.
[10]郑高利,张信岳,孙丽文等.疏肝解郁颗粒抗抑郁作用的研究.中国中医药科技,2004,11：205-207.
[11]魏绪华,汤庆军.自拟百合汤加减治疗抑郁症85例.江苏中医药,2002,23：25.
[12]余菊,罗洁.中药配合心理治疗抑郁症举隅.贵阳中医学院学报,2003,25：20—21.
[13]蒋有倩.中西医结合辨证分型治疗抑郁症30例.辽宁中医杂志,2001,28：236.
[14]Dar A, Khatoon S. Behavioal and biochemical studies of dichloromethane fraction from the Areca catechu nut. Pharmacol Biochem Behav, 2000,65,1-6.
[15]Butterweck V, Nishibe S, SasakiT, etal. Antidepressant effects of apocynum venetum leaves in a forced swimming test. Biol Pharm Bull, 2001,24, 848-851.
[16]张中启,袁莉,赵楠等.巴戟天醇提取物的抗抑郁作用.中国药学杂志,2000,35,739-741.
[17]张中启,黄世杰,袁莉等.巴戟天寡糖对鼠强迫性游泳和获得性无助抑郁模型的影响.中国药理学与毒理学杂志,2001,15,262-265.
[18]李明亚,陈红梅.石菖蒲对行为绝望动物抑郁模型的抗抑郁作用.中药材,2001,24,40-41.
[19]杨晓燕,陈发奎,刘玉兰.石菖蒲抗抑郁药理作用的研究.海军军事医学, 1999,20,16-19.
[20]Woelk H.Comparison of St John's wort and imipramine for treating depression:randomized controlled trial. BMJ, 2000,321,536.
[21]冯晶,肖咏.抑郁症的中医药治疗概况.光明中医,2008,23,1407-1408.
[22]周劲光,杨萧鹏.柴胡龙骨牡蛎汤对慢性应激大鼠的抗抑郁作用.中国实用神经疾病杂志,2010,19,5-7.
[23]李建梅,杨澄,张伟云.半夏厚朴汤醇提取物对大鼠慢性抑郁模型的影响.中国中药杂志,2003,28,55-59.
[24]吕圭源,陈素红.关于中药新药研究中的几点思考.世界科学技术-中医药现代化思路与方法,2004,6：17-20.
[25]冯寿章.重视中药二类新药(有效部位)研究,提高中药新药研制水平.中药新药与临床药理,1998,9：134-137.
[26]赵勤萍,张荣.浅谈中药有效部位研究对中药产业现代化的影响.山西中医,2006,22：48-50.
[27]邵璟,狄留庆,刘产明等.中药有效部位新药研发中关键问题分析.中国新药杂志,2010,19：98-101.
[28]安建忠,许志惠.新技术新方法在中草药提取方面的应用.时珍国医国药,2001,12：465-467.
[29]刘斌,石任兵.大孔吸附树脂吸附分离技术在中药复方纯化分离中的应用.世界科学技术-中医药现代化,2003,5：39-44.
[30]彭蕴茹,钱大玮.百合不同提取部位的药理活性比较.现代中药研究与实践,2006,20：27-28.
[31]李林,张志杰,蔡宝昌.中药百合有效部位的药效学筛选.南京中医药大学学报,2005,21：56-57.
[32]苏娣.桑寄生抗白血病有效部位的体位筛选及其诱导白血病细胞凋亡的实验研究.广州中医药大学2011届硕士学位论文.2011：5.
[33]刘守钾.毛茛总苷对大鼠肾性高血压的影响及有效部位研究.广东药学院2011届硕士学位论文.2011：5.
[34]王春成.独角莲块茎抗肿瘤有效部位的筛选及其化学成分初步研究.东北林业大学2011届硕士学位论文.2011：6.
[35]艾丹.白鲜皮抗炎有效部位的研究.黑龙江中医药大学2010届硕士学位论 文.2010：6.
[36]熊静悦,曾南,张崇燕等.逍遥散抗抑郁作用研究.中药药理与临床.2007,1,3-5.
[37]吴丽丽,徐志伟,严灿等.逍遥散和丹栀逍遥散抗抑郁作用的实验研究.中医药学报.2003,3,16-17.
[38]王海涛,薛黎明,秦雪梅等.慢性不可预知和慢性束缚应激抑郁模型大鼠行为学研究.山西大学学报.2010,33,157-160.
[39]代云桃.基于GC-MS的逍遥散抗应激性抑郁症作用机理的代谢组学初探.山西大学2008届硕士学位论文.2008：6
[40]窦春艳.基于GC/MS尿液代谢组学分析的逍遥散抗抑郁作用研究.山西大学2010届硕士学位论文.2010：6.
[41]郑兴宇.基于GC/MS代谢组学技术的逍遥散抗抑郁作用研究.山西大学2011届硕士学位论文.2011：6.
[42]刘晓节.基于NMR技术的逍遥散抗抑郁代谢组学研究.山西大学2011届硕士学位论文.2011：6.
[43]马致洁.逍遥散抗抑郁活性组分的初步筛选研究.山西大学2010届硕士学位论文.2010：6.
[44]于能江.小补心汤的抗抑郁有效部位及其化学成分研究.中国科学院上海冶金研究所2000届博士学位论文.2000：6.
[45]Nieholson JK, Connelly J, Lindon JC, etal. Metabonomies:A Plat form for studying drug toxicity and gene function. Nat Rev Drug Discov, 2002, 1,153-161.
[46]Jun Yang, Guowang Xu, Qunfa Hong, Hartmut M. Liebich, Katja Lutz, R.M. Schmiilling, Hans Giinther Wahl. Discrimination of Diabetic Patients from Healthy Controls by using metabonomics method based on their Serum Fatty Acid Profiles. J. Chromatogr. B, 2004, 813,53-58.
[47]Principal Component Analysis (PCA) has been documented as a valuable pattern recognition technique for 1H NMR spectral data. Nat. Med. 2002, 8, 1439-1444.
[48]Jun Yang, Guowang Xu, Yufang Zheng, etal. Diagnosis of liver cancer using HPLC-based metabonomics in the aim to avoid the false-positive result from hepatitis and hepatocirrhosis diseases. J. Chromatogr. B, 2004, 813,59-65.
[49]T.A.Clayton, J.C.Lindon, O.Cloarec, etal. Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature, 2006,440,1073-1077.
[50]M.Coen, Y.S.Hong, T.A.Clayton, etal. The mechanism of galactosamine toxicity revisited; a metabonomic study. J. Proteome Res, 2007, 6,2711-2719.
[51]K.Yu, G.Sheng, J.Sheng, etal. A metabonomic investigation on the biochemical perturbation in liver failure patients caused by hepatitis B virus. J. Proteome Res, 2007, 6, 2413-2419.
[52]J.Yang, X.Zhao, X.Liu, C.Wang, P.Gao, J.Wang, L.Li, J.Gu,5.Yang, GXu, J.ProteomeRes.5(2006)554.
[53]杨萍,贾钰华,李杰.代谢组学技术及其在中医药领域中的应用.辽宁中医杂志.2009,36,32-35.
[54]Minjun Chen, Liping Zhao, Wei Jia. Metabonomic study on the biochemical profiles of a hydrocortisone induced animal model. Journal of Proteome Research. 2005,4, 2391-2396.
[55]S.A.Faney, O.Beekonert, GDarbon, etal. Gas chromatography/flame ionisation detection mass spectrometry for the detection of endogenous urine metabolites for metabonomic studies and its use as a complementary tool to nuclear magnetic resonance spectroscopy. Rapid Commun.Mass Spectrom. 2006, 20, 2271-2280.
[56]Y.Xu, F.Gong, S.J.Dixon, etal. Application of Dissimilarity Indices, Principal Coordinates Analysis, and Rank Tests to Peak Tables in Metabolomics of the Gas Chromatography/Mass Spectrometry of Human Sweat. Anal.Chem.2007, 79, 5633-5641.
[57]Trygg J, Holmes E, Lundstedt T. Chemometrics in metabonomics. J. Proteome Res.2007,6,469-479.
[58]黄欣.基于GC-MS代谢组学的肝脏毒理研究及数据处理方法.浙江大学2008届硕士学位论文.2008：6.
[59]Morris M, Watldns SM. Foeused metabolomic Profiling in the drug development proeess:advances from lipid profiling. Current Opinion in Chemical Biology.2005,9, 407-412.
[60]Zhou JL, Xu B, Huang J, et al.'H NMR-based metabonomic and pattern recognition analysis for detection of oral squamous cell carcinoma.Clinica Chimica Acta. 2009, 401, 8-13.
[61]Maher AD, Crockfor D, Toft H, et al.Optimization of human Plasma 1H NMR Spectroscopic data processing for high-throughput metabolic phenotyping studies and detection of insulin resistance related to type 2 diabetes. Analytical Chemistry. 2008 80, 7354-7362.
[62]Stella C, Beckwith-Hall B, Cloarec O, et al. Susceptibility of human metabolic Phenotypes to dietary modulation. Journal of Proteome Research. 2006, 5,2780-2788.
[63]吴春福,李逢利,刘雯等.逍遥散对大鼠脑中单胺类神经递质含量的影响.中药药理与临床.1993,2,8.
[64]毛海燕,叶林,叶向荣.肝郁证大鼠中枢神经递质变化的观察.福建中医药.2002,33,17-18.
[65]高萧枫.逍遥散和柴胡对慢性束缚应激肝郁模型大鼠脑内单胺类神经递质的影响.中国科学院2000届博士学位论文.2000：6.
[66]贾广成,郑兴宇,周玉枝等.逍遥散对CUMS模型大鼠行为学及血浆内单胺类神经递质的影响.中国实验方剂学杂志.2011,17,136-140.
[67]王霞灵,周大桥.肝郁患者血清泌乳素测定临床意义探讨.湖北中医杂志.1995,17,53-54.
[68]刘晓萍.逍遥散加味治疗高催乳素血症81例.陕西中医.2006,27,687.
[69]訾晓梅,刘青云.逍遥口服液药效学研究.安徽中医学院学报.2000,19,39-41.
[70]李秀珍,李家福.逍遥散加味治疗高泌乳素症54例.中西医结合杂志.1991,11,439.
[71]杨玉峰,杨瑛.加味逍遥散对女性黄褐斑血清性激素水平的影响.陕西中医学院学报.2000,23,41-42.
[72]吕志平,刘承才.“肝郁”大鼠血浆TXAZ、 PG几水平与肝微循环变化及逍遥散作用.中国微循环.2000,4,160-161.
[73]王静怡,石玉猖,查鹏洲等.逍遥散的药理研究.中国医院药学杂志.2002,22,489-490.
[74]吴丽丽,徐志伟,严灿等.逍遥散和丹桅逍遥散抗抑郁作用的实验研究.中医研究.2003,16,14-15.
[75]李慧鹏.慢性不可预见性应激大鼠海马BDNF抗抑郁作用机制研究.陕西师范大学2009届硕士学位论文.2009：6.
[76]崔杰,郑兴宇,高晓霞等.逍遥散抗抑郁作用最佳剂量筛选.中国实验方剂学杂志.2010,13,194-198.
[77]姚丽梅,李伟荣,孙龙川.逍遥散与柴胡疏肝散延缓肝郁衰老的实验研究.中国实验方剂学杂志,2006,2,65-66.
[78]徐志伟,敖海清,严灿.逍遥散对慢性心理应激大鼠海马突触体内Ca2+扩大浓度的影响.广州中医药大学学报.2005,22,42-45.
[79]李英,罗朝利.实现中药现代化研发途径分析.中国中医药现代远程教育.2009,7,219-220.
[80]Dai, Y.T., Li, Z.Y., Xue, L.M., et al. Metabolomics study on the anti-depression effect of xiaoyaosan on rat model of chronic unpredictable mild stress. Journal of Ethnopharmacology. 2010,128, 482-489.
[81]Y.Qiu, M.Su, Y Liu, et al. Application of ethyl chloroformate derivatization for gas chromatography-mass spectrometry based metabonomic profiling. Anal.Chim.Aeta. 2007, 583,277-283.
[82]Qi Zhang, Guangji Wang,Yu Du, et al.GC/MS analysis of the rat urine for metabonomic research. Journal of Chromatography B.2007, 854, 20-25.
[83]K.Yu, G Sheng, J. Sheng, et al. A metabonomic investigation on the biochemical perturbation in liver failure patients caused by hepatitis B virus. J. Proteome Res. 2007, 6, 2413-2419.
[84]An, D.Z., Zhang, Q., Wu, S.M., et al. Changes of metabolic profiles in urine after oral administration of quercetin in rats. Food and Chemical Toxicology. 2010, 48,1521-1527.
[85]Bollard, M.E., Holmes, E., Lindon, J.C., et al. Investigations into Biochemical Changes Due to Diurnal Variation and Estrus Cycle in Female Rats Using High-Resolution 1H NMR Spectroscopy of Urine and Pattern Recognition.Analytical Biochemistry. 2001,295,194-202.
[86]Li, L., Sun, B., Zhang, Q., et al. Metabonomic study on the toxicity of Hei-Shun-Pian, the processed lateral root of Aconitum carmichaelii Debx. (Ranunculaceae). Journal of Ethnopharmacology. 2008, 116, 561-568.
[87]Liu, Y.R., Huang, R.Q., Liu, L.J., et al. Metabonomics study of urine from Sprague-Dawley rats exposed to Huang-yao-zi using 1H NMR spectroscopy. Journal of Pharmaceutical and Biomedical Analysis. 2010, 52,136-141.
[88]Nicholls, A.W., Holmes, E., Lindon, J.C., et al.Metabonomic investigations into hydrazine toxicity in the rat. Chemical Research in Toxicology. 2002, 14, 975-987.
[89]Sun, B., Li, L., Wu, S. M., et al. Metabolomic analysis of biofluids from rats treated with Aconitum alkaloids using nuclear magnetic resonance and gas chromatography/time-of-flight mass spectrometry. Analytical Biochemistry. 2009, 395, 125-133.
[90]Wang, Y.L., Tang, H.R., Nicholson, J.K., et al. A metabonomic strategy for the Detection of the Metabolic Effects of Chamomile (Matricaria recutita L.) Ingestion. Journal of Agricultural and Food Chemistry. 2005,53,191-196.
[91]Zhou, Y.H., Xie, H., Wang, T.W., Bai, H.Q.. Extraction of Volatile Oil from Angel ica and its Chemical Components Analysis. Technolog and Development of Chemical Industy. 2007, 36, 33-35.
[92]Wei, X.H., Cheng, X.M., Shen, J.S., Wang, Z.T., Antidepressant effect of Yueju-Wan ethanol extract and its fractions in mice models of despair. Journal of Ethnopharmacology. 2008,117,339-344.
[93]Matsumoto, K., Kohno, S., Ojima, K., Tezuka, Y., Kadota, S., Watanabe, H., Effects of methylenechloride-soluble fration of Japanese angelica root extract, ligustilide and butylidenephthalide, on pentobarbital sleep in grouphoused and socially isolated mice. Life Sciences.1998,62,2073-2082.
[94]Li, X.Q., Song, A.H., Li, W., Chen, X.H., Bi, K.S. Analysis of the Fatty Acid from Bupleurum Chinense DC in China by GC-MS and GC-FID. Chemical and Pharmaceutical Bulletin. 2005,53,1613-1617.
[95]Cocchi, M., Tonello, L., Platelets, fatty acids, depression and ischemic heart disease. Progress in nutrition. 2007, 9, 94-104.
[96]Nicholson JK, Connelly J, Lindon JC, et.al. Metabonomics: a Platform for studying drug toxicity and gene funetion. Nat Rev Drug Discov. 2002, 1,153-161.
[97]Brindle JT, Antti H, Holmes E, et.al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med. 2003,8,1439-1444.
[98]程鹏.人体血清中结合态代谢物的NMR研究.中国科学院2000届硕士学位论文.2000：6.
[99]Sun, B, Li, L, Wu, SM, et.al. Metabolomic analysis of biofluids from rats treated with Aconitum alkaloids using nuclear magnetic resonance and gas chromatography/time-of-flight mass spectrometry. Analytical Biochemistry.2009, 395,125-133.
[100]Wu, QF, Zhang Q, Sun B, et al. 1H NMR-based metabonomic study on the metabolic changes in the plasma of patients with functional dyspepsia and the effect of acupuncture. Journal of Pharmaceutical and Biomedical Analysis. 2010, 51,698-704.
[101]Marianne CW, Lorraine B, J Paul G Malthouse, et.al. Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. Am J Clin Nutr, 2006,84,531-539.
[102]Wei, XH, Cheng, XM, Shen, JS, et al. Antidepressant effect of Yueju-Wan ethanol extract and its fractions in mice models of despair. Journal of Ethnopharmacology, 2008, 117,339-344.
[103]Wyss,M..Creatine and creatine metabolism.Physiological Reviews. 2000,80, 1107-1213.
[104]Ma, C., Bi, K.S., Zhang, M., et.al. Toxicology effects of Morning Glory Seed in rat: A metabonomic method for profiling of urine metabolic changes. Journal of Ethnopharmacology. 2010, 130,134-142.
[105]Ma, C., Bi, K.S., Zhang, M., et.al. Metabonomic study of biochemical changes in the urine of Morning Glory Seed treated rat. Journal of Pharmaceutical and Biomedical Analysis. 2010,53,559-566.
[106]Serretti, A., Mandelli, L., Lattuada, E., et.al. Depressive syndrome in major psychoses:a study on 1351 subjects. Psychiatry Research. 2004, 127, 85-99.
[107]Fiorillo CD, Willianm JT. Glutamate mediatea an inhibitory pestaynapfic potential in dopamine neurons. Nature, 1998, 394, 78-82.
[108]Shimomura Y, Harris RA. Metabolism and physiological function of branched-chain amino acids:Discussion of session. J Nutr 2006,136,232S-233S.
[109]Blomstrand E. A role for branched-chain amino acids in reducing central fatigue. J Nutr 2006,136,544S-547S.
[110]Y Ni, MM Su, JC Lin, et al. Metabolic profiling reveals disorder of amino acid metabolism in four brain regions from a rat model of chronic unpredictable mild stress. FEBS. Lett. 2008,582,2627-2636.
[111]Huang YY, Chen WJ, Li YX, et al.Effects of antidepressant treatment on N-acetyl aspartate and choline levels in the hippocampus and thalami of post-stroke depression patients: A study using H-1 magnetic resonance spectroscopy. Psychiat Res Neuroim, 2010,182,48-52.
[112]Wang, Y.T., Tan, Q.R., Sun, L.L. et al. Possible therapeutic effect of a Traditional Chinese Medicine, si-ni-san, on chronic restraint stress related disorders. Neuroscience Letters. 2009,449,215-219.
[113]Sattari, M.G., Mashayekhi, S., Evaluation of taurine as a biomarker of liver damage in paracetamol poisoning. European Journal of Pharmacology. 2008, 581,171-176.
[114]Bollard, M.E., Contel, N., Ebbels, T., et al. NMR-based metabolic profiling identifies biomarkers of liver regeneration following partial hepatectomy in the rat. Journal of Proteome Research. 2009,6,1-43.
[115]Nicholls AW, Mortishire-Smith RJ, Nicholson JK. NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. Chem Res Toxicol.2003,16,1395-1404.
[116]Schildkraut J J.The caetchoalmine hypothesis of affective disorders:are view of supporitng evdience. J Am J Psychairty.1965,122,509-512.
[117]Delgado, P.L.,Depression: the case for a monoamine deficiency. The Journal of Clinical Psychiatry.2000, 61,7-11.
[118]Yen Kuang Yang,, Tzung Lieh Yeh, Greater availability of dopamine transporters in patients with major depression-A dual-isotope SPECT study Psychiatry Research: Neuroimaging. 2008,162, 230-235.
[119]刘伟.逍遥散干预慢性温和不可预知应激大鼠盲肠菌群及组织研究.山西大学2011届硕士学位论文.2011：6.
[120]Luo L, Nong, WJ, Kong, LD, et al. Antidepressant effects of Banxia Houpu decoction, a traditional Chinese medicinal empirical formula. Journal of Ethnopharmacology, 2000, 73,277-281.
[121]李海芳.甘草苷抗抑郁作用的主要药效及机制研究.北京中医药大学2008届硕士学位论文.2008：5.
[122]曲淼,唐启盛.抑郁症与中医“郁证”的关系探讨.北京中医药大学学报,2004,27,11-13.
[2]王祖承.精神病学.北京,人民卫生出版社,2002,2,112-125.
[3]郭小青,田正良,米金辉.抑郁症中医病因病机分析.浙江中医杂志,2002,37：374-375.
[4]王玲玲,刘兰英.针灸治疗抑郁症临床思路.针灸临床杂志,2003,19：7-9.
[5]杜元灏,李桂平.调神疏肝针法治疗郁证的理论基础.中国针灸,2005,25：143-146.
[6]李新纯,唐武,李庆.疏肝宁神汤治疗抑郁症60例.新中医,2003,35：60-61.
[7]张金茹.小柴胡汤治疗抑郁症40例.北京中医,2003,22：38-39.
[8]贾爱民,温霞.涤痰汤加减治疗抑郁症13例.河南中医,2003,23：26.
[9]张秋菊,王成永,程惠娟等.白金散对绝望行为动物模型的抗抑郁作用及其机理研究.中国中医药科技,2004,11：146-147.
[10]郑高利,张信岳,孙丽文等.疏肝解郁颗粒抗抑郁作用的研究.中国中医药科技,2004,11：205-207.
[11]魏绪华,汤庆军.自拟百合汤加减治疗抑郁症85例.江苏中医药,2002,23：25.
[12]余菊,罗洁.中药配合心理治疗抑郁症举隅.贵阳中医学院学报,2003,25：20—21.
[13]蒋有倩.中西医结合辨证分型治疗抑郁症30例.辽宁中医杂志,2001,28：236.
[14]Dar A, Khatoon S. Behavioal and biochemical studies of dichloromethane fraction from the Areca catechu nut. Pharmacol Biochem Behav, 2000,65,1-6.
[15]Butterweck V, Nishibe S, SasakiT, etal. Antidepressant effects of apocynum venetum leaves in a forced swimming test. Biol Pharm Bull, 2001,24, 848-851.
[16]张中启,袁莉,赵楠等.巴戟天醇提取物的抗抑郁作用.中国药学杂志,2000,35,739-741.
[17]张中启,黄世杰,袁莉等.巴戟天寡糖对鼠强迫性游泳和获得性无助抑郁模型的影响.中国药理学与毒理学杂志,2001,15,262-265.
[18]李明亚,陈红梅.石菖蒲对行为绝望动物抑郁模型的抗抑郁作用.中药材,2001,24,40-41.
[19]杨晓燕,陈发奎,刘玉兰.石菖蒲抗抑郁药理作用的研究.海军军事医学, 1999,20,16-19.
[20]Woelk H.Comparison of St John's wort and imipramine for treating depression:randomized controlled trial. BMJ, 2000,321,536.
[21]冯晶,肖咏.抑郁症的中医药治疗概况.光明中医,2008,23,1407-1408.
[22]周劲光,杨萧鹏.柴胡龙骨牡蛎汤对慢性应激大鼠的抗抑郁作用.中国实用神经疾病杂志,2010,19,5-7.
[23]李建梅,杨澄,张伟云.半夏厚朴汤醇提取物对大鼠慢性抑郁模型的影响.中国中药杂志,2003,28,55-59.
[24]吕圭源,陈素红.关于中药新药研究中的几点思考.世界科学技术-中医药现代化思路与方法,2004,6：17-20.
[25]冯寿章.重视中药二类新药(有效部位)研究,提高中药新药研制水平.中药新药与临床药理,1998,9：134-137.
[26]赵勤萍,张荣.浅谈中药有效部位研究对中药产业现代化的影响.山西中医,2006,22：48-50.
[27]邵璟,狄留庆,刘产明等.中药有效部位新药研发中关键问题分析.中国新药杂志,2010,19：98-101.
[28]安建忠,许志惠.新技术新方法在中草药提取方面的应用.时珍国医国药,2001,12：465-467.
[29]刘斌,石任兵.大孔吸附树脂吸附分离技术在中药复方纯化分离中的应用.世界科学技术-中医药现代化,2003,5：39-44.
[30]彭蕴茹,钱大玮.百合不同提取部位的药理活性比较.现代中药研究与实践,2006,20：27-28.
[31]李林,张志杰,蔡宝昌.中药百合有效部位的药效学筛选.南京中医药大学学报,2005,21：56-57.
[32]苏娣.桑寄生抗白血病有效部位的体位筛选及其诱导白血病细胞凋亡的实验研究.广州中医药大学2011届硕士学位论文.2011：5.
[33]刘守钾.毛茛总苷对大鼠肾性高血压的影响及有效部位研究.广东药学院2011届硕士学位论文.2011：5.
[34]王春成.独角莲块茎抗肿瘤有效部位的筛选及其化学成分初步研究.东北林业大学2011届硕士学位论文.2011：6.
[35]艾丹.白鲜皮抗炎有效部位的研究.黑龙江中医药大学2010届硕士学位论 文.2010：6.
[36]熊静悦,曾南,张崇燕等.逍遥散抗抑郁作用研究.中药药理与临床.2007,1,3-5.
[37]吴丽丽,徐志伟,严灿等.逍遥散和丹栀逍遥散抗抑郁作用的实验研究.中医药学报.2003,3,16-17.
[38]王海涛,薛黎明,秦雪梅等.慢性不可预知和慢性束缚应激抑郁模型大鼠行为学研究.山西大学学报.2010,33,157-160.
[39]代云桃.基于GC-MS的逍遥散抗应激性抑郁症作用机理的代谢组学初探.山西大学2008届硕士学位论文.2008：6
[40]窦春艳.基于GC/MS尿液代谢组学分析的逍遥散抗抑郁作用研究.山西大学2010届硕士学位论文.2010：6.
[41]郑兴宇.基于GC/MS代谢组学技术的逍遥散抗抑郁作用研究.山西大学2011届硕士学位论文.2011：6.
[42]刘晓节.基于NMR技术的逍遥散抗抑郁代谢组学研究.山西大学2011届硕士学位论文.2011：6.
[43]马致洁.逍遥散抗抑郁活性组分的初步筛选研究.山西大学2010届硕士学位论文.2010：6.
[44]于能江.小补心汤的抗抑郁有效部位及其化学成分研究.中国科学院上海冶金研究所2000届博士学位论文.2000：6.
[45]Nieholson JK, Connelly J, Lindon JC, etal. Metabonomies:A Plat form for studying drug toxicity and gene function. Nat Rev Drug Discov, 2002, 1,153-161.
[46]Jun Yang, Guowang Xu, Qunfa Hong, Hartmut M. Liebich, Katja Lutz, R.M. Schmiilling, Hans Giinther Wahl. Discrimination of Diabetic Patients from Healthy Controls by using metabonomics method based on their Serum Fatty Acid Profiles. J. Chromatogr. B, 2004, 813,53-58.
[47]Principal Component Analysis (PCA) has been documented as a valuable pattern recognition technique for 1H NMR spectral data. Nat. Med. 2002, 8, 1439-1444.
[48]Jun Yang, Guowang Xu, Yufang Zheng, etal. Diagnosis of liver cancer using HPLC-based metabonomics in the aim to avoid the false-positive result from hepatitis and hepatocirrhosis diseases. J. Chromatogr. B, 2004, 813,59-65.
[49]T.A.Clayton, J.C.Lindon, O.Cloarec, etal. Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature, 2006,440,1073-1077.
[50]M.Coen, Y.S.Hong, T.A.Clayton, etal. The mechanism of galactosamine toxicity revisited; a metabonomic study. J. Proteome Res, 2007, 6,2711-2719.
[51]K.Yu, G.Sheng, J.Sheng, etal. A metabonomic investigation on the biochemical perturbation in liver failure patients caused by hepatitis B virus. J. Proteome Res, 2007, 6, 2413-2419.
[52]J.Yang, X.Zhao, X.Liu, C.Wang, P.Gao, J.Wang, L.Li, J.Gu,5.Yang, GXu, J.ProteomeRes.5(2006)554.
[53]杨萍,贾钰华,李杰.代谢组学技术及其在中医药领域中的应用.辽宁中医杂志.2009,36,32-35.
[54]Minjun Chen, Liping Zhao, Wei Jia. Metabonomic study on the biochemical profiles of a hydrocortisone induced animal model. Journal of Proteome Research. 2005,4, 2391-2396.
[55]S.A.Faney, O.Beekonert, GDarbon, etal. Gas chromatography/flame ionisation detection mass spectrometry for the detection of endogenous urine metabolites for metabonomic studies and its use as a complementary tool to nuclear magnetic resonance spectroscopy. Rapid Commun.Mass Spectrom. 2006, 20, 2271-2280.
[56]Y.Xu, F.Gong, S.J.Dixon, etal. Application of Dissimilarity Indices, Principal Coordinates Analysis, and Rank Tests to Peak Tables in Metabolomics of the Gas Chromatography/Mass Spectrometry of Human Sweat. Anal.Chem.2007, 79, 5633-5641.
[57]Trygg J, Holmes E, Lundstedt T. Chemometrics in metabonomics. J. Proteome Res.2007,6,469-479.
[58]黄欣.基于GC-MS代谢组学的肝脏毒理研究及数据处理方法.浙江大学2008届硕士学位论文.2008：6.
[59]Morris M, Watldns SM. Foeused metabolomic Profiling in the drug development proeess:advances from lipid profiling. Current Opinion in Chemical Biology.2005,9, 407-412.
[60]Zhou JL, Xu B, Huang J, et al.'H NMR-based metabonomic and pattern recognition analysis for detection of oral squamous cell carcinoma.Clinica Chimica Acta. 2009, 401, 8-13.
[61]Maher AD, Crockfor D, Toft H, et al.Optimization of human Plasma 1H NMR Spectroscopic data processing for high-throughput metabolic phenotyping studies and detection of insulin resistance related to type 2 diabetes. Analytical Chemistry. 2008 80, 7354-7362.
[62]Stella C, Beckwith-Hall B, Cloarec O, et al. Susceptibility of human metabolic Phenotypes to dietary modulation. Journal of Proteome Research. 2006, 5,2780-2788.
[63]吴春福,李逢利,刘雯等.逍遥散对大鼠脑中单胺类神经递质含量的影响.中药药理与临床.1993,2,8.
[64]毛海燕,叶林,叶向荣.肝郁证大鼠中枢神经递质变化的观察.福建中医药.2002,33,17-18.
[65]高萧枫.逍遥散和柴胡对慢性束缚应激肝郁模型大鼠脑内单胺类神经递质的影响.中国科学院2000届博士学位论文.2000：6.
[66]贾广成,郑兴宇,周玉枝等.逍遥散对CUMS模型大鼠行为学及血浆内单胺类神经递质的影响.中国实验方剂学杂志.2011,17,136-140.
[67]王霞灵,周大桥.肝郁患者血清泌乳素测定临床意义探讨.湖北中医杂志.1995,17,53-54.
[68]刘晓萍.逍遥散加味治疗高催乳素血症81例.陕西中医.2006,27,687.
[69]訾晓梅,刘青云.逍遥口服液药效学研究.安徽中医学院学报.2000,19,39-41.
[70]李秀珍,李家福.逍遥散加味治疗高泌乳素症54例.中西医结合杂志.1991,11,439.
[71]杨玉峰,杨瑛.加味逍遥散对女性黄褐斑血清性激素水平的影响.陕西中医学院学报.2000,23,41-42.
[72]吕志平,刘承才.“肝郁”大鼠血浆TXAZ、 PG几水平与肝微循环变化及逍遥散作用.中国微循环.2000,4,160-161.
[73]王静怡,石玉猖,查鹏洲等.逍遥散的药理研究.中国医院药学杂志.2002,22,489-490.
[74]吴丽丽,徐志伟,严灿等.逍遥散和丹桅逍遥散抗抑郁作用的实验研究.中医研究.2003,16,14-15.
[75]李慧鹏.慢性不可预见性应激大鼠海马BDNF抗抑郁作用机制研究.陕西师范大学2009届硕士学位论文.2009：6.
[76]崔杰,郑兴宇,高晓霞等.逍遥散抗抑郁作用最佳剂量筛选.中国实验方剂学杂志.2010,13,194-198.
[77]姚丽梅,李伟荣,孙龙川.逍遥散与柴胡疏肝散延缓肝郁衰老的实验研究.中国实验方剂学杂志,2006,2,65-66.
[78]徐志伟,敖海清,严灿.逍遥散对慢性心理应激大鼠海马突触体内Ca2+扩大浓度的影响.广州中医药大学学报.2005,22,42-45.
[79]李英,罗朝利.实现中药现代化研发途径分析.中国中医药现代远程教育.2009,7,219-220.
[80]Dai, Y.T., Li, Z.Y., Xue, L.M., et al. Metabolomics study on the anti-depression effect of xiaoyaosan on rat model of chronic unpredictable mild stress. Journal of Ethnopharmacology. 2010,128, 482-489.
[81]Y.Qiu, M.Su, Y Liu, et al. Application of ethyl chloroformate derivatization for gas chromatography-mass spectrometry based metabonomic profiling. Anal.Chim.Aeta. 2007, 583,277-283.
[82]Qi Zhang, Guangji Wang,Yu Du, et al.GC/MS analysis of the rat urine for metabonomic research. Journal of Chromatography B.2007, 854, 20-25.
[83]K.Yu, G Sheng, J. Sheng, et al. A metabonomic investigation on the biochemical perturbation in liver failure patients caused by hepatitis B virus. J. Proteome Res. 2007, 6, 2413-2419.
[84]An, D.Z., Zhang, Q., Wu, S.M., et al. Changes of metabolic profiles in urine after oral administration of quercetin in rats. Food and Chemical Toxicology. 2010, 48,1521-1527.
[85]Bollard, M.E., Holmes, E., Lindon, J.C., et al. Investigations into Biochemical Changes Due to Diurnal Variation and Estrus Cycle in Female Rats Using High-Resolution 1H NMR Spectroscopy of Urine and Pattern Recognition.Analytical Biochemistry. 2001,295,194-202.
[86]Li, L., Sun, B., Zhang, Q., et al. Metabonomic study on the toxicity of Hei-Shun-Pian, the processed lateral root of Aconitum carmichaelii Debx. (Ranunculaceae). Journal of Ethnopharmacology. 2008, 116, 561-568.
[87]Liu, Y.R., Huang, R.Q., Liu, L.J., et al. Metabonomics study of urine from Sprague-Dawley rats exposed to Huang-yao-zi using 1H NMR spectroscopy. Journal of Pharmaceutical and Biomedical Analysis. 2010, 52,136-141.
[88]Nicholls, A.W., Holmes, E., Lindon, J.C., et al.Metabonomic investigations into hydrazine toxicity in the rat. Chemical Research in Toxicology. 2002, 14, 975-987.
[89]Sun, B., Li, L., Wu, S. M., et al. Metabolomic analysis of biofluids from rats treated with Aconitum alkaloids using nuclear magnetic resonance and gas chromatography/time-of-flight mass spectrometry. Analytical Biochemistry. 2009, 395, 125-133.
[90]Wang, Y.L., Tang, H.R., Nicholson, J.K., et al. A metabonomic strategy for the Detection of the Metabolic Effects of Chamomile (Matricaria recutita L.) Ingestion. Journal of Agricultural and Food Chemistry. 2005,53,191-196.
[91]Zhou, Y.H., Xie, H., Wang, T.W., Bai, H.Q.. Extraction of Volatile Oil from Angel ica and its Chemical Components Analysis. Technolog and Development of Chemical Industy. 2007, 36, 33-35.
[92]Wei, X.H., Cheng, X.M., Shen, J.S., Wang, Z.T., Antidepressant effect of Yueju-Wan ethanol extract and its fractions in mice models of despair. Journal of Ethnopharmacology. 2008,117,339-344.
[93]Matsumoto, K., Kohno, S., Ojima, K., Tezuka, Y., Kadota, S., Watanabe, H., Effects of methylenechloride-soluble fration of Japanese angelica root extract, ligustilide and butylidenephthalide, on pentobarbital sleep in grouphoused and socially isolated mice. Life Sciences.1998,62,2073-2082.
[94]Li, X.Q., Song, A.H., Li, W., Chen, X.H., Bi, K.S. Analysis of the Fatty Acid from Bupleurum Chinense DC in China by GC-MS and GC-FID. Chemical and Pharmaceutical Bulletin. 2005,53,1613-1617.
[95]Cocchi, M., Tonello, L., Platelets, fatty acids, depression and ischemic heart disease. Progress in nutrition. 2007, 9, 94-104.
[96]Nicholson JK, Connelly J, Lindon JC, et.al. Metabonomics: a Platform for studying drug toxicity and gene funetion. Nat Rev Drug Discov. 2002, 1,153-161.
[97]Brindle JT, Antti H, Holmes E, et.al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med. 2003,8,1439-1444.
[98]程鹏.人体血清中结合态代谢物的NMR研究.中国科学院2000届硕士学位论文.2000：6.
[99]Sun, B, Li, L, Wu, SM, et.al. Metabolomic analysis of biofluids from rats treated with Aconitum alkaloids using nuclear magnetic resonance and gas chromatography/time-of-flight mass spectrometry. Analytical Biochemistry.2009, 395,125-133.
[100]Wu, QF, Zhang Q, Sun B, et al. 1H NMR-based metabonomic study on the metabolic changes in the plasma of patients with functional dyspepsia and the effect of acupuncture. Journal of Pharmaceutical and Biomedical Analysis. 2010, 51,698-704.
[101]Marianne CW, Lorraine B, J Paul G Malthouse, et.al. Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. Am J Clin Nutr, 2006,84,531-539.
[102]Wei, XH, Cheng, XM, Shen, JS, et al. Antidepressant effect of Yueju-Wan ethanol extract and its fractions in mice models of despair. Journal of Ethnopharmacology, 2008, 117,339-344.
[103]Wyss,M..Creatine and creatine metabolism.Physiological Reviews. 2000,80, 1107-1213.
[104]Ma, C., Bi, K.S., Zhang, M., et.al. Toxicology effects of Morning Glory Seed in rat: A metabonomic method for profiling of urine metabolic changes. Journal of Ethnopharmacology. 2010, 130,134-142.
[105]Ma, C., Bi, K.S., Zhang, M., et.al. Metabonomic study of biochemical changes in the urine of Morning Glory Seed treated rat. Journal of Pharmaceutical and Biomedical Analysis. 2010,53,559-566.
[106]Serretti, A., Mandelli, L., Lattuada, E., et.al. Depressive syndrome in major psychoses:a study on 1351 subjects. Psychiatry Research. 2004, 127, 85-99.
[107]Fiorillo CD, Willianm JT. Glutamate mediatea an inhibitory pestaynapfic potential in dopamine neurons. Nature, 1998, 394, 78-82.
[108]Shimomura Y, Harris RA. Metabolism and physiological function of branched-chain amino acids:Discussion of session. J Nutr 2006,136,232S-233S.
[109]Blomstrand E. A role for branched-chain amino acids in reducing central fatigue. J Nutr 2006,136,544S-547S.
[110]Y Ni, MM Su, JC Lin, et al. Metabolic profiling reveals disorder of amino acid metabolism in four brain regions from a rat model of chronic unpredictable mild stress. FEBS. Lett. 2008,582,2627-2636.
[111]Huang YY, Chen WJ, Li YX, et al.Effects of antidepressant treatment on N-acetyl aspartate and choline levels in the hippocampus and thalami of post-stroke depression patients: A study using H-1 magnetic resonance spectroscopy. Psychiat Res Neuroim, 2010,182,48-52.
[112]Wang, Y.T., Tan, Q.R., Sun, L.L. et al. Possible therapeutic effect of a Traditional Chinese Medicine, si-ni-san, on chronic restraint stress related disorders. Neuroscience Letters. 2009,449,215-219.
[113]Sattari, M.G., Mashayekhi, S., Evaluation of taurine as a biomarker of liver damage in paracetamol poisoning. European Journal of Pharmacology. 2008, 581,171-176.
[114]Bollard, M.E., Contel, N., Ebbels, T., et al. NMR-based metabolic profiling identifies biomarkers of liver regeneration following partial hepatectomy in the rat. Journal of Proteome Research. 2009,6,1-43.
[115]Nicholls AW, Mortishire-Smith RJ, Nicholson JK. NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. Chem Res Toxicol.2003,16,1395-1404.
[116]Schildkraut J J.The caetchoalmine hypothesis of affective disorders:are view of supporitng evdience. J Am J Psychairty.1965,122,509-512.
[117]Delgado, P.L.,Depression: the case for a monoamine deficiency. The Journal of Clinical Psychiatry.2000, 61,7-11.
[118]Yen Kuang Yang,, Tzung Lieh Yeh, Greater availability of dopamine transporters in patients with major depression-A dual-isotope SPECT study Psychiatry Research: Neuroimaging. 2008,162, 230-235.
[119]刘伟.逍遥散干预慢性温和不可预知应激大鼠盲肠菌群及组织研究.山西大学2011届硕士学位论文.2011：6.
[120]Luo L, Nong, WJ, Kong, LD, et al. Antidepressant effects of Banxia Houpu decoction, a traditional Chinese medicinal empirical formula. Journal of Ethnopharmacology, 2000, 73,277-281.
[121]李海芳.甘草苷抗抑郁作用的主要药效及机制研究.北京中医药大学2008届硕士学位论文.2008：5.
[122]曲淼,唐启盛.抑郁症与中医“郁证”的关系探讨.北京中医药大学学报,2004,27,11-13.